Human papillomavirus infection in human immunodeficiency virus-positive Taiwanese women incarcerated for illicit drug usage

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 4, 2013, Pages 282-287

  Chu, Fang Yeh ^a,b   Lin, Yu Shiang ^a,c   Cheng, Shu Hsing ^c,d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAOYUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

Drug abuse; Human immunodeficiency virus; Human papillomavirus; Women

Indexed keywords

ILLICIT DRUG; WART VIRUS VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; TAIWAN; UTERINE CERVIX CYTOLOGY;

EID: 84882256865     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.06.009     Document Type: Article

References (24)

1. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338:423-428.
2. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., Garcia P., et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91:226-236.
3. Baay M.F., Kjetland E.F., Ndhlovu P.D., Deschoolmeester V., Mduluza T., Gomo E., et al. Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol 2004, 73:481-485.
4. Blossom D.B., Beigi R.H., Farrell J.J., Mackay W., Qadadri B., Brown D.R., et al. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol 2007, 79:758-765.
5. Strickler H.D., Burk R.D., Fazzari M., Anastos K., Minkoff H., Massad L.S., et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005, 97:577-586.
6. Six C., Heard I., Bergeron C., Orth G., Poveda J.D., Zagury P., et al. Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 1998, 12:1047-1056.
7. Tsai HH, Lee SK, Hsieh WW. The incidence rate of Anti-HIV in heroin addictive patients at Tsao-Tun Psychiatric Center. 43th Annual Congress of Taiwan Society of Psychiatry, Abstract no. 383, 2003, Tainan, Taiwan., Lee SK, Hsieh WW.
8. Chu F.Y., Chiang S.C., Su F.H., Chang Y.Y., Cheng S.H. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan. J Med Virol 2009, 81:973-978.
9. Statistics of communicable diseases and surveillance reports in Taiwan area December 2011, Centers for Disease Control, Centers for Disease Control, Department of Health, Executive Yuan, Taiwan.
10. Statistics of communicable diseases and surveillance reports in Taiwan area December 2007, Centers for Disease Control, Centers for Disease Control, Department of Health, Executive Yuan, Taiwan.
11. Cheng S.H., Chiang S.C., Hsieh Y.L., Chang Y.Y., Liu Y.R., Chu F.Y. Gender difference in the clinical and behavioral characteristics of human immunodeficiency virus-infected injection drug users in Taiwan. J Formos Med Assoc 2007, 106:467-474.
12. Chen M.J., Wu M.Y., Yang J.H., Chao K.H., Yang Y.S., Ho H.N. Increased frequency of genital human papillomavirus infection in human immunodeficiency virus-seropositive Taiwanese women. JFormos Med Assoc 2005, 104:34-38.
13. Cheng SH, Peng EYC, Lyu SY. Characteristics of Male and Female Inmate's Injection Drug Use and Risks for HIV infection. 11th Western Pacific Congress on Chemotherapy and Infectious Diseases, Abstract No. OS6-04, 2008, Taipei, Taiwan.
14. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119.
15. Linear array HPV genotyping test [Package insert] 2006, Roche Molecular System Inc, Roche Molecular System Inc., Branchburg, NJ.
16. Kim Y.T. Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol 2009, 20:1-7.
17. Palefsky J.M., Holly E.A. Chapter 6: immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003, 31:41-46.
18. Jeng C.J., Phdl, Ko M.L., Ling Q.D., Shen J., Lin H.W., et al. Prevalence of cervical human papillomavirus in Taiwanese women. Clin Invest Med 2005, 28:261-266.
19. Lin H., Ma Y.Y., Moh J.S., Ou Y.C., Shen S.Y., ChangChien C.C. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 2006, 101:40-45.
20. Moscicki A.B., Shiboski S., Broering J., Powell K., Clayton L., Jay N., et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998, 132:277-284.
21. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.C., Desy M., et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999, 180:1415-1423.
22. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297:813-819.
23. Cerqueira D.M., de Moraes S., Camara G.N., Amaral F.A., Oyama C.N., dos Santos M.Q., et al. High HPV genetic diversity in women infected with HIV-1 in Brazil. Arch Virol 2007, 152:75-83.
24. Frisch M., Biggar R.J., Goedert J.J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. JNatl Cancer Inst 2000, 92:1500-1510.